{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:26:41Z","timestamp":1790252801637,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VS1-175560"],"award-info":[{"award-number":["VS1-175560"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT90130"],"award-info":[{"award-number":["PJT90130"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MHR-137772"],"award-info":[{"award-number":["MHR-137772"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SBC-171482"],"award-info":[{"award-number":["SBC-171482"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OV3-170344"],"award-info":[{"award-number":["OV3-170344"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ymthe.2025.11.020","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:38:56Z","timestamp":1763627936000},"page":"936-949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesenchymal stromal cells engineered with ACE2 for treatment of receptor-mediated viral lung injury"],"prefix":"10.1016","volume":"34","author":[{"given":"Yuchong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jady","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Rotstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Wybenga-Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Khang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aye Aye","family":"Khine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley A.","family":"Orser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Laffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Matthay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Slutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Mubareka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1714-3038","authenticated-orcid":false,"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.11.020_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s13054-020-03240-7","article-title":"Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey","volume":"24","author":"Tzotzos","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.ymthe.2025.11.020_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.14740\/jocmr4915","article-title":"The Contribution of COVID-19 to Acute Respiratory Distress Syndrome-Related Mortality in the United States","volume":"15","author":"Oud","year":"2023","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.ymthe.2025.11.020_bib3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?","volume":"46","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.11.020_bib5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"Willett","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ymthe.2025.11.020_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2023.12.026","article-title":"Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants","volume":"187","author":"Qu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.11.020_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-024-07849-4","article-title":"Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle","volume":"634","author":"Caserta","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.11.020_bib8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.11.020_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/v15010167","article-title":"A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies","volume":"15","author":"Chatterjee","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.11.020_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Sim\u00f5es E Silva","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.11.020_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2025.11.020_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107470","article-title":"Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concern","volume":"26","author":"Onodera","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2025.11.020_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.11.020_bib16","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","article-title":"Human recombinant soluble ACE2 in severe COVID-19","volume":"8","author":"Zoufaly","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101301","article-title":"Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation. Molecular Therapy","volume":"32","author":"Skeeters","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.11.020_bib18","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S2213-2600(14)70217-6","article-title":"Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis","volume":"2","author":"Walter","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib20","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1164\/rccm.201802-0356OC","article-title":"Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury","volume":"199","author":"Islam","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10565-019-09493-5","article-title":"Current undesrtanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome","volume":"36","author":"Lopes-Pacheco","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ymthe.2025.11.020_bib22","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/trf.14835","article-title":"Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS","volume":"59","author":"Huppert","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.ymthe.2025.11.020_bib23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41422-021-00573-y","article-title":"Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms","volume":"31","author":"Zhu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2025.11.020_bib24","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.2147\/DDDT.S269407","article-title":"Challenges for mesenchymal stem cell-based therapy for COVID-19","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ymthe.2025.11.020_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13287-020-01875-5","article-title":"Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells","volume":"11","author":"Shu","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2025.11.020_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5582\/ddt.2020.03032","article-title":"Can mesenchymal stem cell therapy be the interim management of COVID-19?","volume":"14","author":"Bamba","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.ymthe.2025.11.020_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/rccm.202302-0297OC","article-title":"Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial","volume":"208","author":"Gorman","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12177-009-9042-6","article-title":"Techniques for accurate protein identification in shotgun proteomic studies of human, mouse, bovine, and chicken lenses","volume":"2","author":"Wilmarth","year":"2009","journal-title":"J. Ocul. Biol. Dis. Infor."},{"key":"10.1016\/j.ymthe.2025.11.020_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1074\/mcp.M116.065524","article-title":"Extended Multiplexing of Tandem Mass Tags (TMT) Labeling Reveals Age and High Fat Diet Specific Proteome Changes in Mouse Epididymal Adipose Tissue","volume":"16","author":"Plubell","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ymthe.2025.11.020_bib30","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 \u2014 Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2025.11.020_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1164\/rccm.202306-0969ED","article-title":"Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19-related Acute Respiratory Distress Syndrome","volume":"208","author":"Zhang","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.202201-0157OC","article-title":"A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19","volume":"207","author":"Bowdish","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-03930-4","article-title":"Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial","volume":"26","author":"Monsel","year":"2022","journal-title":"Crit. Care"},{"key":"10.1016\/j.ymthe.2025.11.020_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.11.020_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.718136","article-title":"Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis","volume":"12","author":"Albini","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.11.020_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.11.020_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E2\u2014dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.11.020_bib40","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1073\/pnas.0907996106","article-title":"Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung","volume":"106","author":"Lee","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.11.020_bib41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","article-title":"Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease","volume":"10","author":"Ranganath","year":"2012","journal-title":"Cell stem cell"},{"key":"10.1016\/j.ymthe.2025.11.020_bib42","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3892\/or_00000796","article-title":"Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro","volume":"23","author":"Xu","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ymthe.2025.11.020_bib43","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1021\/acs.jproteome.9b00082","article-title":"Evosep One Enables Robust Deep Proteome Coverage Using Tandem Mass Tags while Significantly Reducing Instrument Time","volume":"18","author":"Krieger","year":"2019","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ymthe.2025.11.020_bib44","doi-asserted-by":"crossref","first-page":"D640","DOI":"10.1093\/nar\/gkad1045","article-title":"MetaboLights: open data repository for metabolomics","volume":"52","author":"Yurekten O","year":"2024","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:30:47Z","timestamp":1770222647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625009608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1525001625009608"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.020","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cells engineered with ACE2 for treatment of receptor-mediated viral lung injury","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}